Acquisitions - Schedule of Unaudited Pro-forma of Results of Operations (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
|
| Deemed dividend from trigger of down round provision feature | $ (231,843,826) | $ (53,341,619) |
| Jamestown Regional Medical Center [Member] | ||
| Net revenue | 19,983,266 | 19,446,732 |
| Net loss from continuing operations | (15,720,672) | (55,305,325) |
| Net loss | (16,155,515) | (59,582,243) |
| Deemed dividend from trigger of down round provision feature | (231,843,826) | (53,341,619) |
| Net loss to common stockholders | $ (247,999,341) | $ (112,923,862) |
| Basic and diluted continuing operations | $ (24.70) | $ (23,537.03) |
| Basic and diluted net loss to common stockholders | $ (24.75) | $ (24,463.57) |
| X | ||||||||||
- Definition Business acquisition pro-forma income loss from basic and diluted net loss to common shareholders. No definition available.
|
| X | ||||||||||
- Definition Per basic and diluted share amount of pro forma income from continuing operations, after tax, as if the business combination had been completed at the beginning of a period. No definition available.
|
| X | ||||||||||
- Definition Business acquisition net Income (loss) to common shareholders. No definition available.
|
| X | ||||||||||
- Definition Deemed dividend from trigger of down round provision feature. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|